Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IM-PreP Study: Pertussis Vaccination in Immunosuppressed Pregnant Women
jRCT1031250832Recruiting
- Start
- Jul 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine in pertussis. Primary endpoint: Maternal anti-PT IgG fold increase. Started Jul 2026; status: recruiting.
02
Drugs
diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on jRCT1031250832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250832.